Search Results | Litt's Drug Eruption and Reaction Database

(2016): Oscanoa Espinoza TJ+, Rev Fac Cien Med Univ Nac Cordoba (Spanish) 73(4), 263 [REVIEW]
(2015): Dobrzynski JM+, Curr Atheroscler Rep 17(2), 477

(2020): Meurer L+, Clin Liver Dis 24(1), 107 [REVIEW]
(2017): Naiqiong W+, Med Sci Monit 23, 5760
(2016): Wang LY+, Br J Clin Pharmacol 82(3), 823
(2015): Bjornsson ES, Arch Toxicol 89(3), 327
(2015): Dobrzynski JM+, Curr Atheroscler Rep 17(2), 477
(2014): Berta E+, Pharmazie 69(6), 42039%

(2021): Alzueta N+, Eur J Hosp Pharm 28(2), 115-117 (1 case)
(2020): Kee PS+, Front Genet Oct (e-Collection) [REVIEW]
(2020): Madgula AS+, Cureus 12(4), e7500 (1 case)
(2020): Mirlesse N+, Age Ageing Mar, Epub ahead of print (1 case) (autoimmune myopathy)
(2020): Nikolic D+, Expert Opin Drug Saf Apr, Epub ahead of print [REVIEW]
(2020): Qasim Agha O+, BMJ Case Rep 13(2), e232391 (1 case)
(2019): Berent T+, Atheroscler Suppl Aug, Epub ahead of print
(2018): Kosinski C+, Rev Med Suisse (French) 14(596), 462 [REVIEW]
(2018): Wooten JM, South Med J 111(1), 39 [REVIEW]
(2017): Guemara R+, Rev Med Suisse (French) 13(562), 1013
(2017): Kim H+, Basic Clin Pharmacol Toxicol 121(5), 40912%
(2017): Millan J+, Clin Investig Arterioscler (Spanish) 29(1), 778%
(2017): Mulchandani R+, Acta Cardiol Nov, Epub ahead of print32–47%
(2017): Nazir S+, J Clin Rheumatol 23(3), 149 [REVIEW] (autoimmune myopathy)
(2016): Pedro-Botet J+, Expert Opin Drug Saf 15(12), 158378%
(2015): Dobrzynski JM+, Curr Atheroscler Rep 17(2), 477
(2014): Ahmad Z, Am J Cardiol 113(10), 1765
(2014): Berta E+, Pharmazie 69(6), 42055%
(2014): Brygger L+, Expert Opin Drug Saf Sep, Epub ahead of print
(2014): Ganga HV+, Am Heart J 168(1), 6 [REVIEW]
(2014): Jiang Y+, Zhonghua Xin Xue Guan Bing Za Zhi (Chinese) 42(11), 905
(2013): Mohassel P+, Muscle Nerve 48(4), 477 [REVIEW] (autoimmune myopathy)
(2011): Abd TT+, Expert Opin Drug Saf 10(3), 373 [REVIEW]

(2021): Safitri N+, Drug Healthc Patient Saf 13, 211-219 [REVIEW]
(2018): Kosinski C+, Rev Med Suisse (French) 14(596), 462 [REVIEW]
(2017): Millan J+, Clin Investig Arterioscler (Spanish) 29(1), 73%
(2016): Ambapkar SN+, J Assoc Physicians India 64(7), 93
(2016): Oscanoa Espinoza TJ+, Rev Fac Cien Med Univ Nac Cordoba (Spanish) 73(4), 263 [REVIEW]
(2016): Pedro-Botet J+, Expert Opin Drug Saf 15(12), 15833%
(2015): Simons JE+, J Clin Lipidol 9(4), 594
(2014): Jiang Y+, Zhonghua Xin Xue Guan Bing Za Zhi (Chinese) 42(11), 905
(2012): Hoffman KB+, PLoS One 7(8), e42866

(2022): Ganta N+, Cureus 14(2), e22273 (1 case / male)
(2021): Alzueta N+, Eur J Hosp Pharm 28(2), 115-117
(2021): Fidalgo C+, Acta Med Port Sep, Online ahead of print (2 cases)
(2020): Huda SA+, Proc (Bayl Univ Med Cent) 34(1), 185-186 (1 case / male)
(2020): Meyer A+, Arthritis Res Ther 22(1), 5 (55 cases)
(2013): Hamann PD+, Autoimmun Rev 12(12), 1177-81 [REVIEW]

(2021): Lin JL+, J Atheroscler Thromb Sep, Online ahead of print
(2021): Yee J+, J Pers Med 11(7), 677 [REVIEW]
(2020): Conte C+, Fundam Clin Pharmacol Feb, Epub ahead of print [REVIEW]
(2020): Mulchandani R+, Expert Opin Drug Saf Jul, Online ahead of print [REVIEW]
(2020): Thomas JP+, Eur J Clin Pharmacol Jul, Online ahead of print [REVIEW]
(2019): Bae HJ+, Korean J Intern Med Aug, Epub ahead of print12%
(2018): Bellosta S+, Expert Opin Drug Saf 17(1), 25 [REVIEW] (from drug interactions)
(2017): Atonstad S, Tidsskr Nor Laegeforen (Norwegian) 137(1), 36
(2015): de Keyser CE+, Eur J Endocrinol 173(2), 155 (low testosterone levels in males)
(2014): Berta E+, Pharmazie 69(6), 42024% (gastrointestinal)
(2014): Desai CS+, BMJ 349, g3743 [REVIEW]

Drugs belonging to restart save